Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03146312 · ClinicalTrials.gov registry record · NA
Effect of a Multivitamin/Multimineral/Phytochemical Dietary Supplement on Indices of Human Health
A NA study, sponsored by USANA Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT03146312: Completed NA study, sponsored by USANA Health Sciences.
NCT03146312 is a NA study that has completed, run by USANA Health Sciences. The registered enrollment target is 24 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03146312, a NA study, has completed, sponsored by USANA Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
This is a global transcriptomics and epigenetic pilot study designed to identify changes in gene expression and DNA methylation patterns following the consumption of an MVM/phytochemical supplement in a small group of healthy subjects. We hypothesize that genome-wide transcriptional and epigenetic studies will elucidate the molecular mechanisms underlying the health benefits associated with MVM/phytochemical supplementation.
Primary Outcome
Gene expression measured by microarray
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT MVM/phytochemical supplement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2017-04-20 |
| Est. Completion | 2017-06-08 |
| Phase | NA |
What the finished NCT03146312 record still lists
NCT03146312 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03146312 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03146312 about?
NCT03146312 is a clinical study titled "Effect of a Multivitamin/Multimineral/Phytochemical Dietary Supplement on Indices of Human Health". This is a global transcriptomics and epigenetic pilot study designed to identify changes in gene expression and DNA methylation patterns following the consumption of an MVM/phytochemical supplement in a small group of healthy subjects. We hypothesize that genome-wide transcriptional and epigenetic s...
What is the current status of trial NCT03146312?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2017-04-20. Estimated completion is 2017-06-08.
What interventions are being tested in trial NCT03146312?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), MVM/phytochemical supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03146312?
This trial is sponsored by USANA Health Sciences, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03146312's enrollment target sits among peer trials
24 1736th of 2000 higher than 246 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI